| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 7 | |
| #2 | United States | 7 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | Canada | 3 | |
| #5 | Hong Kong | 2 | |
| #6 | Brazil | 1 | |
| #7 | Mexico | 1 | |
| #8 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Orlinger Klaus | 22 |
| #2 | Schmidt Sarah | 14 |
| #3 | Cohen Katherine | 11 |
| #4 | Monath Thomas | 10 |
| #5 | Flatz Lukas Roland | 9 |
| #6 | Ring Sandra Stephanie | 9 |
| #7 | Fuhrmann Gerhard | 8 |
| #8 | Watson Elizabeth | 8 |
| #9 | Kiefmann Bettina | 8 |
| #10 | Aspöck Andreas | 7 |
| Publication | Filing date | Title |
|---|---|---|
| AU2017353443A1 | Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccines | |
| CA3023599A1 | Tri-segmented pichinde viruses as vaccine vectors | |
| AU2016348675A1 | Vaccines against Hepatitis B virus | |
| EP3077519A1 | Cmv vaccines |